105 related articles for article (PubMed ID: 8478265)
1. Implication of cohesive binding of a macrolide antibiotic, rokitamycin, to ribosomes from Staphylococcus aureus.
Endou K; Matsuoka M; Taniguchi H; Nakajima Y
J Antibiot (Tokyo); 1993 Mar; 46(3):478-85. PubMed ID: 8478265
[TBL] [Abstract][Full Text] [Related]
2. Adhesive binding of rokitamycin to Staphylococcus aureus ribosomes.
Endou K; Matsuoka M; Nakajima Y
FEMS Microbiol Lett; 1990 Oct; 60(1-2):93-6. PubMed ID: 2283045
[TBL] [Abstract][Full Text] [Related]
3. Labile 50S ribosome from partial macrolide-resistant Staphylococcus aureus.
Endou K; Endoh S; Matsuoka M; Nakajima Y
Biol Pharm Bull; 1993 Mar; 16(3):328-30. PubMed ID: 8364485
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
[TBL] [Abstract][Full Text] [Related]
5. [Postantibiotic effects (PAE's) of macrolide antibiotics evaluated using Bioscreen C method].
Okubo T; Suzuki T; Fujita K; Iyobe S; Inoue M
Jpn J Antibiot; 1995 Apr; 48(4):548-52. PubMed ID: 7783317
[TBL] [Abstract][Full Text] [Related]
6. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Nishiyama T; Yamashita F
Jpn J Antibiot; 1988 Oct; 41(10):1503-16. PubMed ID: 3204657
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Chida T; Nakaya R
Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
[TBL] [Abstract][Full Text] [Related]
8. In vitro assessment of rokitamycin against problem gram-positive cocci.
Hamilton-Miller JM; Maple PA
J Chemother; 1992 Feb; 4(1):6-8. PubMed ID: 1403073
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
Okubo T; Iyobe S; Fujiki Y; Sagai H
Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and localization of a determinant conferring partial macrolide resistance in Staphylococcus aureus carrying plasmid.
Matsuoka M; Endou K; Yagi K; Nakajima Y
Biol Pharm Bull; 1993 Jul; 16(7):711-3. PubMed ID: 8401408
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of YM133, a new semisynthesized macrolide.
Terasawa T; Watanabe M; Okubo T; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jul; 35(7):1370-5. PubMed ID: 1929295
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial activity of rokitamycin against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Dec; 45(12):1609-21. PubMed ID: 1289579
[TBL] [Abstract][Full Text] [Related]
13. [Bacteriological, pharmacokinetic and clinical studies on a rokitamycin dry syrup in the pediatric field].
Toyonaga Y; Sugita M; Joh K; Takahashi T; Watanabe Y; Hori M
Jpn J Antibiot; 1988 Jun; 41(6):720-38. PubMed ID: 3265445
[TBL] [Abstract][Full Text] [Related]
14. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts.
Maizumi N; Tamura Y; Kanai H; Tsutsui T
J Periodontal Res; 2002 Aug; 37(4):250-4. PubMed ID: 12200967
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis and intracellular killing of rokitamycin-exposed staphylococci by human polymorphonuclear leukocytes.
Braga PC; Sala MT; Mancini L; Da Sasso M
Chemotherapy; 1998; 44(1):42-9. PubMed ID: 9444408
[TBL] [Abstract][Full Text] [Related]
18. [A quantitative determination of inducibility by 14 membered ring macrolide antibiotics in inducible resistant Staphylococcus aureus to macrolide-lincosamide-streptogramin B antibiotics].
Kobayashi H; Endou K; Nakajima Y
Yakugaku Zasshi; 1994 Dec; 114(12):1015-20. PubMed ID: 7869234
[TBL] [Abstract][Full Text] [Related]
19. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
Braga PC; Culici M; Dal Sasso M
Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
[TBL] [Abstract][Full Text] [Related]
20. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
Braga PC
J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
